Delivering Positive Newborn Screening Results: Cost Analysis of Existing Practice versus Innovative, Co-Designed Strategies from the ReSPoND Study

Francesco Fusco; Jane Chudleigh; Pru Holder; James R. Bonham; Kevin W. Southern; Alan Simpson; Louise Moody; Ellinor K. Olander; Holly Chinnery; Stephen Morris

doi:10.3390/ijns8010019

Delivering Positive Newborn Screening Results: Cost Analysis of Existing Practice versus Innovative, Co-Designed Strategies from the ReSPoND Study

Francesco Fusco, Jane Chudleigh, Pru Holder, James R. Bonham, Kevin W. Southern, Alan Simpson, Louise Moody, Ellinor K. Olander, Holly Chinnery, Stephen Morris

Research Centre for Arts, Memory and Communities

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

49 Downloads (Pure)

Abstract

Although the communication pathways of Newborn Bloodspot Screening (NBS) are a delicate task, these pathways vary across different conditions and are often not evidence-based. The ReSPoND interventions were co-designed by healthcare professionals alongside parents who had received a positive NBS result for their child. To calculate the cost of these co-designed strategies and the existing communication pathways, we interviewed 71 members of the clinical and laboratory staff of the 13 English NBS laboratories in the English National Health Service. Therefore, a scenario analysis was used to compare the cost of the existing communication pathways to the co-designed strategies delivered by (i) home-visits and (ii) telecommunications. On average, the existing communication pathway cost £447.08 per infant (range: £237.12 to £628.51) or £234,872.75 (£3635.99 to £1,932,986.23) nationally. Implementing the new interventions relying on home-visits exclusively would cost on average £521.62 (£312.84 to £646.39) per infant and £297,816.03 (£4506.37 to £2,550,284.64) nationally, or £447.19 (£235.79 to £552.03) and £231,342.40 (£3923.7 to £1,922,192.22) if implemented via teleconsultations, respectively. The new strategies delivered are not likely to require additional resources compared with current practice. Further research is needed to investigate whether this investment represents good value for money for the NHS budget.

Original language	English
Article number	19
Pages (from-to)	19
Number of pages	9
Journal	International Journal of Neonatal Screening
Volume	8
Issue number	1
DOIs	https://doi.org/10.3390/ijns8010019
Publication status	Published - 14 Mar 2022

Bibliographical note

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Funder

This project was funded by the National Institute for Health Research Health Services and Delivery Research (NIHR HS&DR) Programme (project number 16/52/25). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. Visit the HS&DR website for more information https://www.journalslibrary.nihr.ac.uk/ programmes/hsdr/165225/#/ (accessed on 2 March 2022). The funders provided a scientific critique of the proposed study design, methods of data collection and analysis. The Funders and Sponsor were not involved in the interpretation of the data and in writing the manuscript. Publisher Copyright: © 2022 by the authors. Licensee MDPI, Basel, Switzerland.

Keywords

Health services research
health economics
genetics

Access to Document

10.3390/ijns8010019Licence: CC BY

PublishedFinal published version, 1.03 MBLicence: CC BY

Cite this

Fusco, F., Chudleigh, J., Holder, P., Bonham, J. R., Southern, K. W., Simpson, A., Moody, L., Olander, E. K., Chinnery, H., & Morris, S. (2022). Delivering Positive Newborn Screening Results: Cost Analysis of Existing Practice versus Innovative, Co-Designed Strategies from the ReSPoND Study. International Journal of Neonatal Screening, 8(1), 19. Article 19. https://doi.org/10.3390/ijns8010019

Fusco, F, Chudleigh, J, Holder, P, Bonham, JR, Southern, KW, Simpson, A, Moody, L, Olander, EK, Chinnery, H & Morris, S 2022, 'Delivering Positive Newborn Screening Results: Cost Analysis of Existing Practice versus Innovative, Co-Designed Strategies from the ReSPoND Study', International Journal of Neonatal Screening, vol. 8, no. 1, 19, pp. 19. https://doi.org/10.3390/ijns8010019

@article{5e505b012b0c4dd9b476c6a3f0da9a7b,

title = "Delivering Positive Newborn Screening Results: Cost Analysis of Existing Practice versus Innovative, Co-Designed Strategies from the ReSPoND Study",

abstract = "Although the communication pathways of Newborn Bloodspot Screening (NBS) are a delicate task, these pathways vary across different conditions and are often not evidence-based. The ReSPoND interventions were co-designed by healthcare professionals alongside parents who had received a positive NBS result for their child. To calculate the cost of these co-designed strategies and the existing communication pathways, we interviewed 71 members of the clinical and laboratory staff of the 13 English NBS laboratories in the English National Health Service. Therefore, a scenario analysis was used to compare the cost of the existing communication pathways to the co-designed strategies delivered by (i) home-visits and (ii) telecommunications. On average, the existing communication pathway cost £447.08 per infant (range: £237.12 to £628.51) or £234,872.75 (£3635.99 to £1,932,986.23) nationally. Implementing the new interventions relying on home-visits exclusively would cost on average £521.62 (£312.84 to £646.39) per infant and £297,816.03 (£4506.37 to £2,550,284.64) nationally, or £447.19 (£235.79 to £552.03) and £231,342.40 (£3923.7 to £1,922,192.22) if implemented via teleconsultations, respectively. The new strategies delivered are not likely to require additional resources compared with current practice. Further research is needed to investigate whether this investment represents good value for money for the NHS budget.",

keywords = "Health services research, health economics, genetics",

author = "Francesco Fusco and Jane Chudleigh and Pru Holder and Bonham, {James R.} and Southern, {Kevin W.} and Alan Simpson and Louise Moody and Olander, {Ellinor K.} and Holly Chinnery and Stephen Morris",

note = "This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",

year = "2022",

month = mar,

day = "14",

doi = "10.3390/ijns8010019",

language = "English",

volume = "8",

pages = "19",

journal = "International Journal of Neonatal Screening",

issn = "2409-515X",

publisher = "MDPI AG",

number = "1",

}

TY - JOUR

T1 - Delivering Positive Newborn Screening Results: Cost Analysis of Existing Practice versus Innovative, Co-Designed Strategies from the ReSPoND Study

AU - Fusco, Francesco

AU - Chudleigh, Jane

AU - Holder, Pru

AU - Bonham, James R.

AU - Southern, Kevin W.

AU - Simpson, Alan

AU - Moody, Louise

AU - Olander, Ellinor K.

AU - Chinnery, Holly

AU - Morris, Stephen

N1 - This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PY - 2022/3/14

Y1 - 2022/3/14

N2 - Although the communication pathways of Newborn Bloodspot Screening (NBS) are a delicate task, these pathways vary across different conditions and are often not evidence-based. The ReSPoND interventions were co-designed by healthcare professionals alongside parents who had received a positive NBS result for their child. To calculate the cost of these co-designed strategies and the existing communication pathways, we interviewed 71 members of the clinical and laboratory staff of the 13 English NBS laboratories in the English National Health Service. Therefore, a scenario analysis was used to compare the cost of the existing communication pathways to the co-designed strategies delivered by (i) home-visits and (ii) telecommunications. On average, the existing communication pathway cost £447.08 per infant (range: £237.12 to £628.51) or £234,872.75 (£3635.99 to £1,932,986.23) nationally. Implementing the new interventions relying on home-visits exclusively would cost on average £521.62 (£312.84 to £646.39) per infant and £297,816.03 (£4506.37 to £2,550,284.64) nationally, or £447.19 (£235.79 to £552.03) and £231,342.40 (£3923.7 to £1,922,192.22) if implemented via teleconsultations, respectively. The new strategies delivered are not likely to require additional resources compared with current practice. Further research is needed to investigate whether this investment represents good value for money for the NHS budget.

AB - Although the communication pathways of Newborn Bloodspot Screening (NBS) are a delicate task, these pathways vary across different conditions and are often not evidence-based. The ReSPoND interventions were co-designed by healthcare professionals alongside parents who had received a positive NBS result for their child. To calculate the cost of these co-designed strategies and the existing communication pathways, we interviewed 71 members of the clinical and laboratory staff of the 13 English NBS laboratories in the English National Health Service. Therefore, a scenario analysis was used to compare the cost of the existing communication pathways to the co-designed strategies delivered by (i) home-visits and (ii) telecommunications. On average, the existing communication pathway cost £447.08 per infant (range: £237.12 to £628.51) or £234,872.75 (£3635.99 to £1,932,986.23) nationally. Implementing the new interventions relying on home-visits exclusively would cost on average £521.62 (£312.84 to £646.39) per infant and £297,816.03 (£4506.37 to £2,550,284.64) nationally, or £447.19 (£235.79 to £552.03) and £231,342.40 (£3923.7 to £1,922,192.22) if implemented via teleconsultations, respectively. The new strategies delivered are not likely to require additional resources compared with current practice. Further research is needed to investigate whether this investment represents good value for money for the NHS budget.

KW - Health services research

KW - health economics

KW - genetics

UR - http://www.scopus.com/inward/record.url?scp=85127062649&partnerID=8YFLogxK

U2 - 10.3390/ijns8010019

DO - 10.3390/ijns8010019

M3 - Article

SN - 2409-515X

VL - 8

SP - 19

JO - International Journal of Neonatal Screening

JF - International Journal of Neonatal Screening

IS - 1

M1 - 19

ER -

Delivering Positive Newborn Screening Results: Cost Analysis of Existing Practice versus Innovative, Co-Designed Strategies from the ReSPoND Study

Abstract

Bibliographical note

Funder

Keywords

Access to Document

Other files and links

Fingerprint

Cite this